RGEN
Medical Instruments & Supplies · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Repligen Corp publishes a filing, an earnings call transcript or a press release.
Get RGEN alertsJason Garland is recorded as CFO at Repligen Corp (RGEN) and CFO at Integer Holdings Corp (ITGR). The proxy statement of Repligen Corp reports total compensation of $2,988,322 for Jason Garland in fiscal 2025, including a base salary of $566,500. Disclosed compensation is on record for 8 fiscal years. Jason Garland has spoken on 24 earnings calls and 3 other investor events across 2 companies, most recently for Repligen Corp on September 9, 2026. Those appearances were for Repligen Corp (RGEN) and Integer Holdings Corp (ITGR). Repligen Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Integer Holdings Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Repligen Corp includes Olivier Loeillot (CEO and Board Member), Dr. Martin D. Madaus (Chairman and Board Member), Martin D. Madaus (Chairman) and 7 others.
“Yeah, and when you look at those synergies, you know, we feel like they're pretty straightforward, right? So we called out about $20 million in year one, you know, most of that, 15 of that is in the OPEC side, very much tied to public company costs, leadership costs, right?”
“Today we are happy to share our excellent financial results for the second quarter of 2026. These results in an improving environment have increased our conviction in our 2026 outlook.”
“I want to echo Olivier's excitement about this transaction. This is a unique opportunity for us to add a differentiated and scaled asset that serves a growing end market and is accreted to our financial profile across the board.”
“Yeah, no, look, we started the year, in our view, executing exactly what we set out to do, right? So we had a strong first quarter, better than expectations, certainly on a top-line basis, as well as earnings.”
“Today we are reporting our financial results for the first quarter of 2026 and providing updated guidance for the full year of 2026. Unless otherwise noted, all financial measures discussed reflect adjusted non-GAAP measures.”
RGEN
Medical Instruments & Supplies · Healthcare
CFO
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Repligen Corp (RGEN) | CFO | $566,500 | $2,988,322 |
| 2024 | Repligen Corp (RGEN) | CFO | $550,000 | $2,107,416 |
| 2023 | Integer Holdings Corp (ITGR) | Former Executive Vice President and Chief Financial Officer | $195,408 | $2,326,532 |
| 2023 | Repligen Corp (RGEN) | CFO | $137,500 | $2,026,471 |
| 2022 | Integer Holdings Corp (ITGR) | Former Executive Vice President and Chief Financial Officer | $541,327 | $3,160,549 |
| 2021 | Integer Holdings Corp (ITGR) | Former Executive Vice President and Chief Financial Officer | $504,981 | $1,882,215 |
| 2020 | Integer Holdings Corp (ITGR) | Executive Vice President and Chief Financial Officer | $498,846 | $1,702,647 |
| 2019 | Integer Holdings Corp (ITGR) | Executive Vice President and Chief Financial Officer | $445,000 | $1,879,934 |
| 2018 | Integer Holdings Corp (ITGR) | Executive Vice President and Chief Financial Officer | $99,231 | $796,284 |